ResMed Inc. (ASX:RMD) Reports Q1 2025 Financial Results
ResMed Inc. (ASX:RMD) reports Q1 2025 revenues up 8% and diluted EPS of $2.48, declaring a $0.53 dividend per share.
Category: ASX-RMD
ResMed Inc.
Latest News
Linius Technologies (ASX:LNU) Launches $3.3M Capital Raising and Appoints Board Members
Lunnon Metals (ASX:LM8) Completes Robust Scoping Study for Lady Herial Deposit
Aurizon Holdings Limited (ASX:AZJ) Awarded BHP Copper Logistics Contracts
Tourism Holdings Limited (ASX:THL) Receives Unsolicited Offer
Meridian Energy Limited (ASX:MEZ) Releases May 2025 Operating Report
4DS Memory Limited (ASX:4DS) Updates on Sixth Platform Lot Analysis
Santos Limited (ASX:STO) Receives Indicative Acquisition Proposal from XRG Consortium
Accent Group Limited (ASX:AX1) Releases FY25 Trading Update
Challenger Limited (ASX:CGF) Supports APRA’s New Annuity Capital Settings
ASX Limited (ASX:ASX) Completes Sale of Investment in Digital Asset
The Hub of Australian Finance News